Skip to main content
All lobbying filings

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $220,000.00 expenses · posted Apr 20, 2026

Official filing document

 Bills named in this filing 4
 Lobbying activity 3
Pharmacy

Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages; H.R. 5316, the Drug Shortage Compounding Patient Access Act of 2025; S. 3794 / H.R. 6509, The Safe Drugs Act; S. 3788, The Clear Labels Act

Medicare/Medicaid

Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees

Budget/Appropriations

Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem